WPRIM Management System> DCMS> Clinical and Molecular Hepatology> 2019> 25> 4

Volume: 25 Issue: 4

1. Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access Page:417—419
2. Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steato hepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internists Page:412—416
3. Persistent elevation of aminotransferases in liver transplant in association with chronic norovirus infection Page:408—411
4. An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection Page:400—407
5. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B Page:390—399
6. Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients Page:381—389
7. Incidence and risk factors of dysphagia after variceal band ligation Page:374—380
8. Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand Page:366—373
9. Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure Page:360—365
10. Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation? Page:354—359
11. Ultraselective conventional transarterial chemoembolization: When and how? Page:344—353
12. Detect or not to detect very early stage hepatocellular carcinoma? The western perspective Page:335—343
13. A leap for the journal: Clinical and Molecular Hepatology enters a new era Page:333—334